Drugs for Celiac Treatment See Progress
October 5, 2018
A clinical trial, designed to test the new drug, NexVax2 has started and the first participating patient has received their vaccine. In addition to that, CypCel has been tested, ZED 1227 has moved to phase 2 in clinical trials, and Larazotide Acetate is close to becoming the first drug for celiac disease to reach phase